Universal Infant Hepatitis B Virus (HBV) Vaccination for 35 Years: Moving Toward the Eradication of HBV

被引：21
|
作者：
Chang, Kai-Chi [1 ,2 ]
Chang, Mei-Hwei [1 ,3 ]
Chen, Huey-Ling [1 ,3 ,4 ]
Wu, Jia-Feng [1 ]
Chang, Chin-Hao [5 ]
Hsu, Hong-Yuan [1 ,4 ]
Ni, Yen-Hsuan [1 ,3 ]
机构：
[1] Natl Taiwan Univ, Coll Med & Hosp, Dept Pediat, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med & Hosp, Hepatitis Res Ctr, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med & Hosp, Med Educ & Bioeth, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med & Hosp, Med Res, Taipei, Taiwan
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 225卷 / 03期
关键词：
hepatitis B; mother-to-infant transmission; occult HBV infection; vaccination; HEPATOCELLULAR-CARCINOMA; INFECTION; CHILDREN; TRANSMISSION; SEROEPIDEMIOLOGY; IMMUNIZATION; ADOLESCENTS; PROGRAM; TAIWAN;
D O I：
10.1093/infdis/jiab401
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A universal hepatitis B virus (HBV) vaccination program has been implemented in Taiwan since 1984. A total of 1611 individuals in Taipei were enrolled to monitor long-term efficacy. The prevalences of hepatitis B surface antigen (HBsAg) and hepatitis B core antibody in the vaccinated birth cohort were lower than in those born before 1984 (0.4% vs 7.7%, and 2.2% vs 50.8%, respectively; P < .0001). Three vaccine-failure carriers all were born to HBsAg-carrier mothers, probably due to no antiviral intervention during pregnancy. Occult HBV infection was rare in the postvaccination era. High vaccination coverage, comprehensive HBV screening, and antiviral agents for pregnant mothers will be essential to eliminate HBV transmission. Universal hepatitis B virus (HBV) vaccination effectively prevented chronic HBV infection. High vaccination coverage, comprehensive screening, and antiviral agents for pregnant mothers are essential to eliminate its perinatal transmission and for future elimination.
引用
收藏
页码：431 / 435
页数：5
相关论文
共 50 条
  • [1] The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
    Nicola Coppola
    Anna Rita Corvino
    Stefania De Pascalis
    Giuseppe Signoriello
    Eliana Di Fiore
    Albert Nienhaus
    Evangelista Sagnelli
    Monica Lamberti
    [J]. BMC Infectious Diseases, 15
  • [2] The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
    Coppola, Nicola
    Corvino, Anna Rita
    De Pascalis, Stefania
    Signoriello, Giuseppe
    Di Fiore, Eliana
    Nienhaus, Albert
    Sagnelli, Evangelista
    Lamberti, Monica
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [3] Breakthrough Hepatitis B Virus (HBV) Infection From Mother-to-Infant Transmission Is the Key Problem Hindering HBV Eradication
    Su, Wei-Ju
    Chen, Huey-Ling
    Chang, Mei-Hwei
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (06): : 1036 - 1037
  • [4] Immunity to Hepatitis B Virus (HBV) Infection Two Decades after Implementation of Universal Infant HBV Vaccination: Association of Detectable Residual Antibodies and Response to a Single HBV Challenge Dose
    Spradling, Philip R.
    Xing, Jian
    Williams, Roxanne
    Masunu-Faleafaga, Yolanda
    Dulski, Theresa
    Mahamud, Abdirahman
    Drobeniuc, Jan
    Teshale, Eyasu H.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (04) : 559 - 561
  • [5] Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada
    Huynh, Chris
    Minuk, Gerald Y.
    Uhanova, Julia
    Baikie, Maureen
    Wong, Thomas
    Osiowy, Carla
    [J]. VACCINE, 2017, 35 (35) : 4515 - 4522
  • [6] Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada
    Osiowy, Carla
    Huynh, Chris
    Minuk, Gerald
    Uhanova, Julia
    Baikie, Maureen
    Vardy, Lianne
    Wong, Thomas
    [J]. INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2016, 75 : 6 - 6
  • [7] Serological and Molecular Epidemiological Outcomes after Two Decades of Universal Infant Hepatitis B Virus (HBV) Vaccination in Nunavut, Canada
    Huynh, Chris
    Minuk, Gerald Y.
    Uhanova, Julia
    Baikie, Maureen
    Vardy, Lianne
    Wong, Thomas
    Osiowy, Carla
    [J]. HEPATOLOGY, 2014, 60 : 975A - 975A
  • [8] Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
    Pisaturo, Mariantonietta
    Macera, Margherita
    Alessio, Loredana
    Calo, Federica
    Coppola, Nicola
    [J]. VIRUSES-BASEL, 2019, 11 (09):
  • [9] Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudineresistant HBV reactivation following hepatitis B surface antigen seroconversion
    Gerolami, Rene
    Borentain, Patrick
    Colson, Philippe
    Norguet, Emmanuelle
    Gerolami, Andre
    Tamalet, Catherine
    [J]. LIVER INTERNATIONAL, 2007, 27 (10) : 1417 - 1421
  • [10] Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy
    Paola Scognamiglio
    Enrico Girardi
    Mario Fusco
    Pierluca Piselli
    Silvana Russo Spena
    Carmela Maione
    Francesco Aurelio Pisanti
    Diego Serraino
    [J]. BMC Infectious Diseases, 9
12345